ArticleJournal of diabetes research2016
Cost-Effectiveness of a Short Message Service Intervention to Prevent Type 2 Diabetes from Impaired Glucose Tolerance.
Article in Journal of diabetes research, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01556880 (A Randomized Controlled Trial of Short Message Service by Cellular Phone for Professional Drivers With Pre-diabetes), which is not on this map. Cited by 17 papers, 7 of them syntheses that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
A Randomized Controlled Trial of Short Message Service by Cellular Phone for Professional Drivers With Pre-diabetes
Who cites it
17 citing papers in PubMed, 7 syntheses or guidelines pooled it, 35 citations in OpenAlex.
- Pooled it
- Text messages as a tool to improve cardiovascular disease risk factors control: a systematic review and meta-analysis of randomized clinical trials.BMC public health · 2025Pooled it
- Application of decision analytical models to diabetes in low- and middle-income countries: a systematic review.BMC health services research · 2022Pooled it
- Economic Evaluation of Health Behavior Interventions to Prevent and Manage Type 2 Diabetes Mellitus in Asia: A Systematic Review of Randomized Controlled Trials.International journal of environmental research and public health · 2022Pooled it
- Pooled it
- Decision models of prediabetes populations: A systematic review.Diabetes, obesity & metabolism · 2019Pooled it
- What is the economic evidence for mHealth? A systematic review of economic evaluations of mHealth solutions.PloS one · 2017Pooled it
- Five-year effectiveness of short messaging service (SMS) for pre-diabetes.BMC research notes · 2018Trial
- Cost effectiveness review of text messaging, smartphone application, and website interventions targeting T2DM or hypertension.NPJ digital medicine · 2023Review
- Correlation between retinal vascular parameters and cystatin C in patients with type 2 diabetes.Acta diabetologica · 2021Article
- TEXT4myBACK - The Development Process of a Self-Management Intervention Delivered Via Text Message for Low Back Pain.Archives of rehabilitation research and clinical translation · 2021Article
- Preventing relapse with personalized smart-messaging after cognitive behavioural therapy: A proof-of-concept evaluation.The British journal of clinical psychology · 2020Article
- Methodology of the health economic evaluation of the Feel4Diabetes-study.BMC endocrine disorders · 2020Article
- Article
- Using smart-messaging to enhance mindfulness-based cognitive therapy for cancer patients: A mixed methods proof of concept evaluation.Psycho-oncology · 2020Article
- Article
- Effectiveness of digital health using the transtheoretical model to prevent or delay type 2 diabetes in impaired glucose tolerance patients: protocol for a randomized control trial.BMC public health · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors at 2 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Aims. To investigate the costs and cost-effectiveness of a short message service (SMS) intervention to prevent the onset of type 2 diabetes mellitus (T2DM) in subjects with impaired glucose tolerance (IGT). Methods. A Markov model was developed to simulate the cost and effectiveness outcomes of the SMS intervention and usual clinical practice from the health provider's perspective. The direct programme costs and the two-year SMS intervention costs were evaluated in subjects with IGT. All costs were expressed in 2011 US dollars. The incremental cost-effectiveness ratio was calculated as cost per T2DM onset prevented, cost per life year gained, and cost per quality adjusted life year (QALY) gained. Results. Within the two-year trial period, the net intervention cost of the SMS group was $42.03 per subject. The SMS intervention managed to reduce 5.05% onset of diabetes, resulting in saving $118.39 per subject over two years. In the lifetime model, the SMS intervention dominated the control by gaining an additional 0.071 QALY and saving $1020.35 per person. The SMS intervention remained dominant in all sensitivity analyses. Conclusions. The SMS intervention for IGT subjects had the superiority of lower monetary cost and a considerable improvement in preventing or delaying the T2DM onset. This trial is registered with ClinicalTrials.gov NCT01556880.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.